| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Obesity | 134 | 2024 | 2262 | 17.340 |
Why?
|
| Research Design | 34 | 2024 | 692 | 8.980 |
Why?
|
| Energy Intake | 39 | 2024 | 493 | 6.960 |
Why?
|
| Weight Loss | 39 | 2024 | 482 | 6.870 |
Why?
|
| Body Mass Index | 71 | 2023 | 1561 | 5.800 |
Why?
|
| Randomized Controlled Trials as Topic | 35 | 2024 | 1108 | 5.650 |
Why?
|
| Body Weight | 41 | 2024 | 996 | 5.380 |
Why?
|
| Longevity | 18 | 2024 | 137 | 5.080 |
Why?
|
| Data Interpretation, Statistical | 26 | 2022 | 231 | 5.010 |
Why?
|
| Nutritional Sciences | 12 | 2021 | 76 | 4.690 |
Why?
|
| Pediatric Obesity | 13 | 2020 | 383 | 4.150 |
Why?
|
| Feeding Behavior | 18 | 2023 | 711 | 3.910 |
Why?
|
| Body Composition | 36 | 2024 | 522 | 3.470 |
Why?
|
| Bias | 12 | 2022 | 131 | 3.160 |
Why?
|
| Models, Genetic | 24 | 2020 | 759 | 3.150 |
Why?
|
| Overweight | 14 | 2023 | 363 | 2.880 |
Why?
|
| Eating | 17 | 2023 | 374 | 2.880 |
Why?
|
| Weight Gain | 20 | 2024 | 405 | 2.740 |
Why?
|
| Public Health | 7 | 2023 | 262 | 2.700 |
Why?
|
| Exercise | 9 | 2023 | 813 | 2.690 |
Why?
|
| Schools | 8 | 2023 | 220 | 2.640 |
Why?
|
| Humans | 270 | 2024 | 124618 | 2.620 |
Why?
|
| Weight Reduction Programs | 5 | 2019 | 55 | 2.550 |
Why?
|
| Diet, Reducing | 11 | 2021 | 89 | 2.530 |
Why?
|
| Energy Metabolism | 25 | 2024 | 775 | 2.490 |
Why?
|
| Diet | 18 | 2023 | 1136 | 2.300 |
Why?
|
| Random Allocation | 11 | 2022 | 436 | 2.300 |
Why?
|
| Models, Statistical | 25 | 2018 | 471 | 2.280 |
Why?
|
| Breakfast | 4 | 2023 | 11 | 2.160 |
Why?
|
| Statistics as Topic | 7 | 2018 | 256 | 2.110 |
Why?
|
| Biomedical Research | 8 | 2019 | 517 | 2.090 |
Why?
|
| Quantitative Trait Loci | 16 | 2012 | 288 | 2.070 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 17 | 2011 | 1016 | 2.070 |
Why?
|
| Nutritional Status | 7 | 2023 | 314 | 2.020 |
Why?
|
| Caloric Restriction | 13 | 2024 | 83 | 2.010 |
Why?
|
| Dietary Supplements | 9 | 2022 | 476 | 1.980 |
Why?
|
| Social Class | 7 | 2019 | 190 | 1.890 |
Why?
|
| Adipose Tissue | 19 | 2024 | 462 | 1.870 |
Why?
|
| Computer Simulation | 20 | 2022 | 646 | 1.700 |
Why?
|
| Beverages | 7 | 2019 | 100 | 1.700 |
Why?
|
| Anti-Obesity Agents | 10 | 2012 | 41 | 1.690 |
Why?
|
| Periodicals as Topic | 7 | 2016 | 198 | 1.560 |
Why?
|
| Female | 138 | 2024 | 66495 | 1.490 |
Why?
|
| Male | 133 | 2024 | 61200 | 1.480 |
Why?
|
| Health Promotion | 5 | 2018 | 389 | 1.460 |
Why?
|
| Dietary Fats | 11 | 2020 | 295 | 1.440 |
Why?
|
| Cluster Analysis | 11 | 2023 | 398 | 1.440 |
Why?
|
| Reproducibility of Results | 25 | 2022 | 2876 | 1.440 |
Why?
|
| Cardiovascular Diseases | 10 | 2022 | 1947 | 1.390 |
Why?
|
| Breast Feeding | 4 | 2023 | 218 | 1.390 |
Why?
|
| Aging | 9 | 2022 | 1182 | 1.350 |
Why?
|
| Chromosome Mapping | 18 | 2010 | 1079 | 1.350 |
Why?
|
| Blood Glucose | 11 | 2022 | 1138 | 1.280 |
Why?
|
| Scientific Experimental Error | 2 | 2020 | 2 | 1.280 |
Why?
|
| Adult | 77 | 2023 | 29440 | 1.280 |
Why?
|
| Food | 6 | 2018 | 125 | 1.250 |
Why?
|
| Retraction of Publication as Topic | 2 | 2020 | 4 | 1.200 |
Why?
|
| Motor Activity | 9 | 2015 | 522 | 1.190 |
Why?
|
| Reproduction | 5 | 2021 | 237 | 1.190 |
Why?
|
| Models, Biological | 8 | 2024 | 1459 | 1.170 |
Why?
|
| Metformin | 3 | 2019 | 151 | 1.170 |
Why?
|
| Fruit | 5 | 2020 | 219 | 1.160 |
Why?
|
| Editorial Policies | 2 | 2020 | 53 | 1.130 |
Why?
|
| Waist Circumference | 4 | 2016 | 90 | 1.110 |
Why?
|
| Sample Size | 6 | 2022 | 86 | 1.090 |
Why?
|
| Peer Review, Research | 4 | 2016 | 47 | 1.080 |
Why?
|
| Causality | 5 | 2022 | 83 | 1.060 |
Why?
|
| Exercise Therapy | 3 | 2023 | 153 | 1.040 |
Why?
|
| Appetite Regulation | 5 | 2013 | 41 | 1.030 |
Why?
|
| Diabetes Mellitus, Type 2 | 8 | 2020 | 1269 | 1.010 |
Why?
|
| Hypoglycemic Agents | 5 | 2019 | 442 | 1.010 |
Why?
|
| Data Collection | 3 | 2018 | 382 | 0.990 |
Why?
|
| Ghrelin | 4 | 2023 | 53 | 0.990 |
Why?
|
| Waist-Hip Ratio | 5 | 2010 | 56 | 0.960 |
Why?
|
| Vegetables | 4 | 2016 | 261 | 0.960 |
Why?
|
| Selection, Genetic | 5 | 2011 | 154 | 0.960 |
Why?
|
| Enteral Nutrition | 2 | 2018 | 256 | 0.950 |
Why?
|
| Animals | 68 | 2024 | 34088 | 0.940 |
Why?
|
| School Health Services | 3 | 2015 | 99 | 0.940 |
Why?
|
| Environment | 7 | 2016 | 145 | 0.920 |
Why?
|
| Parenting | 3 | 2018 | 331 | 0.910 |
Why?
|
| Statistics, Nonparametric | 4 | 2021 | 429 | 0.900 |
Why?
|
| Regression Analysis | 14 | 2020 | 778 | 0.900 |
Why?
|
| Bayes Theorem | 13 | 2011 | 284 | 0.890 |
Why?
|
| Cooking | 2 | 2023 | 38 | 0.890 |
Why?
|
| Physical Fitness | 2 | 2023 | 90 | 0.890 |
Why?
|
| Models, Theoretical | 6 | 2018 | 358 | 0.880 |
Why?
|
| Dietary Sucrose | 3 | 2013 | 41 | 0.860 |
Why?
|
| Child | 36 | 2023 | 24374 | 0.850 |
Why?
|
| Antipsychotic Agents | 7 | 2013 | 361 | 0.840 |
Why?
|
| Nutrition Assessment | 3 | 2021 | 136 | 0.840 |
Why?
|
| Appetite | 1 | 2023 | 37 | 0.830 |
Why?
|
| Music | 1 | 2023 | 17 | 0.820 |
Why?
|
| Actinidia | 1 | 2022 | 3 | 0.820 |
Why?
|
| Health Education | 2 | 2015 | 220 | 0.810 |
Why?
|
| Prunus dulcis | 1 | 2022 | 1 | 0.800 |
Why?
|
| Evidence-Based Practice | 2 | 2014 | 112 | 0.800 |
Why?
|
| Anthropometry | 8 | 2017 | 199 | 0.800 |
Why?
|
| Epistasis, Genetic | 8 | 2008 | 93 | 0.800 |
Why?
|
| Genome, Human | 7 | 2012 | 1273 | 0.800 |
Why?
|
| Absorptiometry, Photon | 6 | 2019 | 177 | 0.790 |
Why?
|
| Solanum tuberosum | 1 | 2022 | 16 | 0.790 |
Why?
|
| Ascorbic Acid | 1 | 2022 | 78 | 0.790 |
Why?
|
| Perception | 5 | 2018 | 218 | 0.790 |
Why?
|
| Quantitative Trait, Heritable | 6 | 2011 | 106 | 0.780 |
Why?
|
| Carbonated Beverages | 2 | 2013 | 11 | 0.770 |
Why?
|
| Genetic Linkage | 5 | 2006 | 453 | 0.770 |
Why?
|
| Child Nutritional Physiological Phenomena | 4 | 2015 | 173 | 0.770 |
Why?
|
| Information Dissemination | 1 | 2024 | 186 | 0.760 |
Why?
|
| Computational Biology | 5 | 2006 | 811 | 0.760 |
Why?
|
| Adiposity | 10 | 2021 | 190 | 0.760 |
Why?
|
| Cholesterol | 7 | 2016 | 537 | 0.760 |
Why?
|
| Obesity, Abdominal | 2 | 2020 | 37 | 0.760 |
Why?
|
| Research Support as Topic | 3 | 2011 | 63 | 0.750 |
Why?
|
| Lactation | 1 | 2023 | 193 | 0.750 |
Why?
|
| Sweetening Agents | 3 | 2011 | 33 | 0.740 |
Why?
|
| Gene Expression Profiling | 13 | 2010 | 1702 | 0.730 |
Why?
|
| Coffee | 1 | 2021 | 24 | 0.720 |
Why?
|
| Adolescent | 30 | 2023 | 19278 | 0.720 |
Why?
|
| Mice | 34 | 2024 | 17639 | 0.710 |
Why?
|
| Blueberry Plants | 1 | 2020 | 6 | 0.700 |
Why?
|
| Mice, Inbred C57BL | 20 | 2024 | 4409 | 0.700 |
Why?
|
| Food Preferences | 5 | 2017 | 117 | 0.700 |
Why?
|
| Plant Extracts | 2 | 2021 | 119 | 0.690 |
Why?
|
| Self Report | 8 | 2019 | 512 | 0.690 |
Why?
|
| Moxibustion | 1 | 2020 | 1 | 0.680 |
Why?
|
| Social Marketing | 1 | 2020 | 9 | 0.680 |
Why?
|
| Middle Aged | 52 | 2023 | 26714 | 0.670 |
Why?
|
| Correspondence as Topic | 1 | 2020 | 12 | 0.670 |
Why?
|
| Mothers | 1 | 2023 | 351 | 0.670 |
Why?
|
| Genetic Techniques | 5 | 2009 | 106 | 0.670 |
Why?
|
| Malus | 1 | 2019 | 6 | 0.670 |
Why?
|
| Insulin-Like Growth Factor I | 2 | 2024 | 341 | 0.670 |
Why?
|
| Terminology as Topic | 4 | 2010 | 222 | 0.660 |
Why?
|
| Writing | 1 | 2020 | 62 | 0.660 |
Why?
|
| Young Adult | 16 | 2022 | 9014 | 0.660 |
Why?
|
| Cocos | 1 | 2019 | 2 | 0.650 |
Why?
|
| Goals | 3 | 2020 | 129 | 0.650 |
Why?
|
| Risk Factors | 24 | 2020 | 10270 | 0.650 |
Why?
|
| Research Personnel | 1 | 2020 | 117 | 0.640 |
Why?
|
| Phenotype | 21 | 2015 | 4256 | 0.640 |
Why?
|
| Metabolic Syndrome | 5 | 2015 | 338 | 0.640 |
Why?
|
| Vitamin D | 1 | 2020 | 161 | 0.630 |
Why?
|
| Genetic Markers | 13 | 2012 | 604 | 0.630 |
Why?
|
| Child Nutrition Sciences | 1 | 2019 | 19 | 0.630 |
Why?
|
| Research Report | 1 | 2019 | 75 | 0.630 |
Why?
|
| Endocrine Disruptors | 2 | 2010 | 51 | 0.620 |
Why?
|
| Satiation | 2 | 2023 | 23 | 0.620 |
Why?
|
| Heredity | 2 | 2018 | 15 | 0.620 |
Why?
|
| Motivational Interviewing | 1 | 2019 | 46 | 0.620 |
Why?
|
| Genomics | 5 | 2007 | 1503 | 0.620 |
Why?
|
| Cardiovascular System | 1 | 2020 | 105 | 0.610 |
Why?
|
| Video Games | 1 | 2020 | 90 | 0.610 |
Why?
|
| Sodium-Glucose Transporter 2 | 1 | 2018 | 17 | 0.600 |
Why?
|
| Physical Endurance | 2 | 2015 | 43 | 0.590 |
Why?
|
| Educational Status | 3 | 2017 | 273 | 0.590 |
Why?
|
| Pregnancy Complications | 1 | 2023 | 512 | 0.590 |
Why?
|
| Models, Educational | 1 | 2018 | 74 | 0.590 |
Why?
|
| Homosexuality, Female | 1 | 2018 | 3 | 0.590 |
Why?
|
| Linear Models | 7 | 2022 | 671 | 0.590 |
Why?
|
| Linkage Disequilibrium | 5 | 2008 | 309 | 0.580 |
Why?
|
| Photography | 1 | 2018 | 95 | 0.580 |
Why?
|
| Evidence-Based Medicine | 3 | 2014 | 635 | 0.580 |
Why?
|
| Dietary Carbohydrates | 4 | 2019 | 119 | 0.570 |
Why?
|
| Dementia | 1 | 2023 | 452 | 0.570 |
Why?
|
| Mortality | 3 | 2005 | 238 | 0.570 |
Why?
|
| Maternal Behavior | 2 | 2015 | 67 | 0.570 |
Why?
|
| Nutritional Physiological Phenomena | 4 | 2016 | 93 | 0.570 |
Why?
|
| Genetics | 2 | 2009 | 24 | 0.570 |
Why?
|
| Obesity, Morbid | 3 | 2011 | 187 | 0.570 |
Why?
|
| Elephants | 4 | 2023 | 40 | 0.560 |
Why?
|
| Health Behavior | 4 | 2021 | 381 | 0.560 |
Why?
|
| Nutrition Surveys | 10 | 2016 | 293 | 0.550 |
Why?
|
| Diet, Fat-Restricted | 3 | 2015 | 40 | 0.550 |
Why?
|
| Food Supply | 2 | 2017 | 101 | 0.540 |
Why?
|
| Body Height | 5 | 2015 | 215 | 0.540 |
Why?
|
| Demography | 1 | 2017 | 240 | 0.540 |
Why?
|
| Genetic Predisposition to Disease | 11 | 2015 | 3153 | 0.540 |
Why?
|
| Genome-Wide Association Study | 6 | 2012 | 1684 | 0.540 |
Why?
|
| Gastric Bypass | 1 | 2017 | 71 | 0.540 |
Why?
|
| Practice Guidelines as Topic | 4 | 2021 | 1267 | 0.540 |
Why?
|
| Sexual and Gender Minorities | 1 | 2018 | 63 | 0.530 |
Why?
|
| Choice Behavior | 3 | 2014 | 132 | 0.530 |
Why?
|
| Pilot Projects | 6 | 2020 | 1388 | 0.530 |
Why?
|
| Hunger | 3 | 2013 | 50 | 0.520 |
Why?
|
| Public Health Systems Research | 1 | 2016 | 1 | 0.520 |
Why?
|
| Risk | 4 | 2013 | 755 | 0.520 |
Why?
|
| Brassica | 1 | 2016 | 14 | 0.520 |
Why?
|
| Fructose | 3 | 2011 | 62 | 0.520 |
Why?
|
| Polymorphism, Genetic | 5 | 2006 | 811 | 0.510 |
Why?
|
| Law Enforcement | 1 | 2016 | 15 | 0.510 |
Why?
|
| Police | 1 | 2016 | 9 | 0.510 |
Why?
|
| United States | 27 | 2018 | 10891 | 0.510 |
Why?
|
| Poverty | 2 | 2017 | 422 | 0.500 |
Why?
|
| Postprandial Period | 2 | 2019 | 77 | 0.500 |
Why?
|
| Fast Foods | 2 | 2014 | 35 | 0.490 |
Why?
|
| Aged | 29 | 2019 | 19703 | 0.490 |
Why?
|
| Phentermine | 2 | 2011 | 7 | 0.480 |
Why?
|
| Life Style | 5 | 2023 | 406 | 0.480 |
Why?
|
| Patient Participation | 2 | 2015 | 221 | 0.480 |
Why?
|
| Rehabilitation | 1 | 2015 | 28 | 0.470 |
Why?
|
| Health Policy | 3 | 2014 | 213 | 0.470 |
Why?
|
| Restaurants | 1 | 2014 | 15 | 0.470 |
Why?
|
| Algorithms | 10 | 2014 | 1619 | 0.470 |
Why?
|
| Publications | 2 | 2014 | 33 | 0.470 |
Why?
|
| Play and Playthings | 1 | 2014 | 17 | 0.470 |
Why?
|
| Cross-Sectional Studies | 16 | 2017 | 3424 | 0.470 |
Why?
|
| Sleep Deprivation | 1 | 2015 | 50 | 0.470 |
Why?
|
| Genetic Variation | 7 | 2012 | 1497 | 0.460 |
Why?
|
| Publication Bias | 3 | 2017 | 14 | 0.460 |
Why?
|
| Drug Prescriptions | 1 | 2016 | 221 | 0.460 |
Why?
|
| Crowdsourcing | 1 | 2014 | 10 | 0.460 |
Why?
|
| Nuts | 1 | 2014 | 16 | 0.450 |
Why?
|
| Insulin | 8 | 2024 | 1202 | 0.450 |
Why?
|
| Genetics, Population | 4 | 2010 | 188 | 0.450 |
Why?
|
| Fabaceae | 1 | 2014 | 24 | 0.440 |
Why?
|
| Diagnostic Self Evaluation | 2 | 2012 | 21 | 0.440 |
Why?
|
| Sleep | 2 | 2015 | 344 | 0.440 |
Why?
|
| Comprehension | 1 | 2014 | 75 | 0.440 |
Why?
|
| Research | 2 | 2015 | 263 | 0.440 |
Why?
|
| Autism Spectrum Disorder | 1 | 2019 | 384 | 0.440 |
Why?
|
| Reproductive Behavior | 1 | 2013 | 7 | 0.440 |
Why?
|
| Motivation | 2 | 2015 | 316 | 0.440 |
Why?
|
| Gait | 1 | 2015 | 145 | 0.440 |
Why?
|
| Diet, High-Fat | 3 | 2024 | 212 | 0.440 |
Why?
|
| Critical Illness | 1 | 2018 | 603 | 0.430 |
Why?
|
| Authorship | 1 | 2013 | 29 | 0.430 |
Why?
|
| Cholesterol, LDL | 2 | 2015 | 569 | 0.430 |
Why?
|
| Inheritance Patterns | 1 | 2013 | 127 | 0.420 |
Why?
|
| Rats | 8 | 2022 | 3677 | 0.420 |
Why?
|
| Cookbooks as Topic | 1 | 2012 | 2 | 0.420 |
Why?
|
| Genome | 2 | 2006 | 472 | 0.410 |
Why?
|
| Appetite Depressants | 2 | 2010 | 22 | 0.410 |
Why?
|
| Life Expectancy | 1 | 2013 | 53 | 0.410 |
Why?
|
| Behavior, Animal | 2 | 2015 | 493 | 0.410 |
Why?
|
| Walking | 1 | 2015 | 212 | 0.410 |
Why?
|
| Epidemiologic Studies | 2 | 2010 | 43 | 0.410 |
Why?
|
| Crohn Disease | 1 | 2016 | 283 | 0.400 |
Why?
|
| Life Tables | 1 | 2012 | 28 | 0.400 |
Why?
|
| Drug Approval | 1 | 2012 | 42 | 0.400 |
Why?
|
| Fertility | 2 | 2016 | 257 | 0.400 |
Why?
|
| Plethysmography | 1 | 2012 | 35 | 0.390 |
Why?
|
| Air | 1 | 2012 | 25 | 0.390 |
Why?
|
| Alleles | 7 | 2010 | 1615 | 0.390 |
Why?
|
| Lipoproteins, LDL | 2 | 2011 | 122 | 0.380 |
Why?
|
| Observational Studies as Topic | 4 | 2016 | 87 | 0.380 |
Why?
|
| Publishing | 4 | 2020 | 109 | 0.380 |
Why?
|
| Food Labeling | 1 | 2011 | 10 | 0.370 |
Why?
|
| Depressive Disorder | 1 | 2014 | 450 | 0.370 |
Why?
|
| Medication Adherence | 1 | 2015 | 396 | 0.370 |
Why?
|
| Treatment Outcome | 12 | 2022 | 12324 | 0.370 |
Why?
|
| Myocardial Ischemia | 1 | 2014 | 340 | 0.360 |
Why?
|
| Cyclobutanes | 1 | 2010 | 6 | 0.360 |
Why?
|
| Patient Education as Topic | 1 | 2014 | 437 | 0.360 |
Why?
|
| Fractures, Bone | 1 | 2013 | 187 | 0.360 |
Why?
|
| Sex Factors | 9 | 2024 | 1280 | 0.360 |
Why?
|
| Consensus | 1 | 2014 | 646 | 0.360 |
Why?
|
| Dioxins | 1 | 2010 | 3 | 0.350 |
Why?
|
| Genotype | 15 | 2011 | 2556 | 0.350 |
Why?
|
| Telomere | 3 | 2019 | 213 | 0.350 |
Why?
|
| Hydrocarbons, Chlorinated | 1 | 2010 | 11 | 0.350 |
Why?
|
| Body Fat Distribution | 1 | 2010 | 28 | 0.350 |
Why?
|
| Primary Health Care | 2 | 2021 | 771 | 0.350 |
Why?
|
| Body Constitution | 6 | 2005 | 36 | 0.340 |
Why?
|
| Deoxyglucose | 1 | 2010 | 33 | 0.340 |
Why?
|
| Biomimetics | 1 | 2010 | 16 | 0.340 |
Why?
|
| Rats, Inbred F344 | 1 | 2010 | 105 | 0.340 |
Why?
|
| Stilbenes | 1 | 2010 | 36 | 0.340 |
Why?
|
| Guidelines as Topic | 3 | 2019 | 197 | 0.330 |
Why?
|
| Software | 4 | 2012 | 683 | 0.330 |
Why?
|
| Stress, Psychological | 1 | 2014 | 545 | 0.330 |
Why?
|
| Cross-Over Studies | 6 | 2019 | 313 | 0.330 |
Why?
|
| Lipid Metabolism | 2 | 2011 | 356 | 0.330 |
Why?
|
| Mannans | 1 | 2009 | 11 | 0.330 |
Why?
|
| Blood Pressure | 5 | 2016 | 1352 | 0.330 |
Why?
|
| Breast Neoplasms | 3 | 2019 | 2498 | 0.330 |
Why?
|
| Pediatrics | 1 | 2019 | 1163 | 0.330 |
Why?
|
| Drug-Related Side Effects and Adverse Reactions | 2 | 2009 | 257 | 0.320 |
Why?
|
| Age Factors | 10 | 2015 | 2818 | 0.320 |
Why?
|
| Language | 1 | 2010 | 200 | 0.320 |
Why?
|
| Abdominal Fat | 2 | 2011 | 19 | 0.320 |
Why?
|
| Chromosomes, Human, Pair 11 | 3 | 2010 | 86 | 0.320 |
Why?
|
| Health Knowledge, Attitudes, Practice | 2 | 2014 | 841 | 0.320 |
Why?
|
| Models, Animal | 2 | 2015 | 461 | 0.310 |
Why?
|
| Metabolic Diseases | 2 | 2011 | 129 | 0.310 |
Why?
|
| Basal Metabolism | 4 | 2013 | 95 | 0.310 |
Why?
|
| C-Reactive Protein | 2 | 2009 | 428 | 0.310 |
Why?
|
| Crosses, Genetic | 6 | 2006 | 163 | 0.300 |
Why?
|
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2015 | 732 | 0.300 |
Why?
|
| Industry | 1 | 2008 | 29 | 0.300 |
Why?
|
| Observation | 1 | 2008 | 42 | 0.300 |
Why?
|
| Patients | 1 | 2009 | 118 | 0.300 |
Why?
|
| Soy Foods | 1 | 2008 | 9 | 0.300 |
Why?
|
| Double-Blind Method | 7 | 2019 | 1637 | 0.300 |
Why?
|
| Suicide, Attempted | 1 | 2009 | 128 | 0.290 |
Why?
|
| Parent-Child Relations | 3 | 2014 | 244 | 0.290 |
Why?
|
| Environmental Pollutants | 1 | 2008 | 68 | 0.290 |
Why?
|
| Polymorphism, Single Nucleotide | 11 | 2015 | 2634 | 0.290 |
Why?
|
| Follow-Up Studies | 7 | 2018 | 5145 | 0.290 |
Why?
|
| Smoking Cessation | 2 | 2006 | 198 | 0.280 |
Why?
|
| Meta-Analysis as Topic | 1 | 2008 | 157 | 0.280 |
Why?
|
| Corn Oil | 1 | 2007 | 11 | 0.280 |
Why?
|
| Family | 4 | 2022 | 562 | 0.280 |
Why?
|
| Cognition | 3 | 2020 | 721 | 0.280 |
Why?
|
| Alzheimer Disease | 3 | 2015 | 799 | 0.280 |
Why?
|
| Suicide | 1 | 2009 | 170 | 0.280 |
Why?
|
| Headache | 1 | 2008 | 107 | 0.280 |
Why?
|
| Fatty Acids, Unsaturated | 1 | 2007 | 65 | 0.280 |
Why?
|
| Databases, Genetic | 2 | 2008 | 473 | 0.270 |
Why?
|
| Child, Preschool | 13 | 2023 | 14009 | 0.270 |
Why?
|
| Disease | 1 | 2008 | 129 | 0.270 |
Why?
|
| Quality Control | 3 | 2018 | 119 | 0.270 |
Why?
|
| Dopamine Uptake Inhibitors | 1 | 2006 | 34 | 0.270 |
Why?
|
| Bupropion | 1 | 2006 | 28 | 0.270 |
Why?
|
| Insulin Resistance | 4 | 2015 | 637 | 0.260 |
Why?
|
| Uric Acid | 2 | 2018 | 94 | 0.260 |
Why?
|
| Animals, Zoo | 3 | 2023 | 15 | 0.260 |
Why?
|
| Stroke | 1 | 2014 | 984 | 0.260 |
Why?
|
| Cohort Studies | 9 | 2013 | 4795 | 0.260 |
Why?
|
| Quality of Life | 3 | 2023 | 1916 | 0.260 |
Why?
|
| Genes | 1 | 2007 | 445 | 0.250 |
Why?
|
| Analysis of Variance | 7 | 2009 | 1014 | 0.250 |
Why?
|
| Longitudinal Studies | 6 | 2023 | 1322 | 0.250 |
Why?
|
| Equipment Failure Analysis | 1 | 2006 | 85 | 0.250 |
Why?
|
| Risperidone | 4 | 2013 | 59 | 0.250 |
Why?
|
| Glucose | 2 | 2022 | 880 | 0.250 |
Why?
|
| Proteomics | 2 | 2006 | 500 | 0.250 |
Why?
|
| Twins, Monozygotic | 4 | 2012 | 117 | 0.250 |
Why?
|
| Aged, 80 and over | 8 | 2019 | 6533 | 0.250 |
Why?
|
| Mental Disorders | 2 | 2009 | 820 | 0.250 |
Why?
|
| Chromosomes, Human, Pair 10 | 1 | 2005 | 64 | 0.250 |
Why?
|
| Glutamate Decarboxylase | 1 | 2005 | 37 | 0.250 |
Why?
|
| Synephrine | 1 | 2005 | 1 | 0.240 |
Why?
|
| Cyclic GMP-Dependent Protein Kinases | 1 | 2005 | 14 | 0.240 |
Why?
|
| Citrus | 1 | 2005 | 6 | 0.240 |
Why?
|
| Drug Combinations | 4 | 2011 | 267 | 0.240 |
Why?
|
| Skin Neoplasms | 1 | 2012 | 808 | 0.240 |
Why?
|
| Muscle, Skeletal | 6 | 2013 | 947 | 0.240 |
Why?
|
| Diabetes Mellitus | 3 | 2021 | 872 | 0.240 |
Why?
|
| Alkaloids | 1 | 2005 | 35 | 0.240 |
Why?
|
| Biology | 1 | 2005 | 29 | 0.240 |
Why?
|
| Reference Standards | 1 | 2006 | 238 | 0.240 |
Why?
|
| Gene Frequency | 6 | 2015 | 722 | 0.240 |
Why?
|
| Plants, Medicinal | 1 | 2004 | 23 | 0.240 |
Why?
|
| Nonprescription Drugs | 1 | 2005 | 50 | 0.230 |
Why?
|
| Pregnancy | 4 | 2023 | 7183 | 0.230 |
Why?
|
| Sexual Behavior | 1 | 2006 | 244 | 0.230 |
Why?
|
| Phytotherapy | 1 | 2004 | 49 | 0.230 |
Why?
|
| Monte Carlo Method | 4 | 2013 | 95 | 0.230 |
Why?
|
| Knowledge | 1 | 2004 | 47 | 0.230 |
Why?
|
| Disease Outbreaks | 1 | 2006 | 320 | 0.230 |
Why?
|
| Neoplasms | 3 | 2015 | 2772 | 0.230 |
Why?
|
| Receptor, Cannabinoid, CB1 | 1 | 2004 | 28 | 0.220 |
Why?
|
| Molecular Biology | 1 | 2004 | 79 | 0.220 |
Why?
|
| Quality Assurance, Health Care | 1 | 2006 | 206 | 0.220 |
Why?
|
| Gene Expression Regulation | 5 | 2010 | 2521 | 0.220 |
Why?
|
| Health Surveys | 5 | 2013 | 239 | 0.220 |
Why?
|
| Logistic Models | 5 | 2013 | 1805 | 0.220 |
Why?
|
| Oxygen Consumption | 3 | 2015 | 305 | 0.210 |
Why?
|
| Costs and Cost Analysis | 2 | 2018 | 164 | 0.210 |
Why?
|
| Time Factors | 7 | 2018 | 6293 | 0.210 |
Why?
|
| Dairy Products | 2 | 2020 | 45 | 0.210 |
Why?
|
| Mexican Americans | 1 | 2004 | 204 | 0.210 |
Why?
|
| Dietary Proteins | 3 | 2024 | 251 | 0.210 |
Why?
|
| Food, Formulated | 1 | 2003 | 52 | 0.210 |
Why?
|
| Tablets | 1 | 2022 | 28 | 0.200 |
Why?
|
| Hyperphagia | 2 | 2013 | 45 | 0.200 |
Why?
|
| Glucosides | 2 | 2018 | 47 | 0.200 |
Why?
|
| Membrane Transport Proteins | 1 | 2003 | 176 | 0.200 |
Why?
|
| Psychology, Child | 1 | 2002 | 44 | 0.200 |
Why?
|
| Piperidines | 1 | 2004 | 204 | 0.200 |
Why?
|
| Television | 1 | 2023 | 72 | 0.200 |
Why?
|
| Decision Trees | 1 | 2022 | 49 | 0.190 |
Why?
|
| Vitamins | 1 | 2022 | 108 | 0.190 |
Why?
|
| Diseases in Twins | 1 | 2002 | 94 | 0.190 |
Why?
|
| Likelihood Functions | 5 | 2009 | 113 | 0.190 |
Why?
|
| Parents | 2 | 2019 | 1015 | 0.190 |
Why?
|
| Surveys and Questionnaires | 5 | 2020 | 3694 | 0.190 |
Why?
|
| Caffeine | 2 | 2017 | 70 | 0.190 |
Why?
|
| Obesity Management | 1 | 2021 | 2 | 0.190 |
Why?
|
| Survival Analysis | 3 | 2013 | 1496 | 0.190 |
Why?
|
| Osteoarthritis | 1 | 2023 | 86 | 0.190 |
Why?
|
| Pyrazoles | 1 | 2004 | 306 | 0.190 |
Why?
|
| Patient Compliance | 3 | 2014 | 471 | 0.190 |
Why?
|
| Twins, Dizygotic | 3 | 2012 | 42 | 0.180 |
Why?
|
| Probability | 3 | 2013 | 323 | 0.180 |
Why?
|
| Attitude to Health | 1 | 2003 | 255 | 0.180 |
Why?
|
| Water | 1 | 2022 | 186 | 0.180 |
Why?
|
| Temperature | 2 | 2016 | 303 | 0.180 |
Why?
|
| Counseling | 1 | 2023 | 216 | 0.180 |
Why?
|
| Predictive Value of Tests | 4 | 2015 | 2154 | 0.180 |
Why?
|
| Birth Weight | 1 | 2023 | 346 | 0.180 |
Why?
|
| Child Behavior | 2 | 2014 | 230 | 0.180 |
Why?
|
| Prevalence | 6 | 2015 | 2445 | 0.180 |
Why?
|
| Acarbose | 1 | 2020 | 4 | 0.180 |
Why?
|
| Genetic Therapy | 1 | 2005 | 679 | 0.180 |
Why?
|
| Selection Bias | 2 | 2014 | 22 | 0.180 |
Why?
|
| Proportional Hazards Models | 4 | 2013 | 1350 | 0.180 |
Why?
|
| Haplotypes | 4 | 2010 | 521 | 0.180 |
Why?
|
| Age Distribution | 2 | 2016 | 414 | 0.180 |
Why?
|
| History, 21st Century | 2 | 2020 | 267 | 0.170 |
Why?
|
| Fatty Acids | 2 | 2017 | 346 | 0.170 |
Why?
|
| Infant | 3 | 2023 | 12468 | 0.170 |
Why?
|
| Precision Medicine | 1 | 2023 | 319 | 0.170 |
Why?
|
| Metabolome | 1 | 2022 | 294 | 0.170 |
Why?
|
| Courage | 1 | 2020 | 4 | 0.170 |
Why?
|
| Schizophrenia | 1 | 2003 | 300 | 0.170 |
Why?
|
| Sex Distribution | 3 | 2013 | 302 | 0.170 |
Why?
|
| Milk, Human | 1 | 2023 | 299 | 0.170 |
Why?
|
| Tropism | 1 | 2019 | 9 | 0.170 |
Why?
|
| Circadian Rhythm | 1 | 2022 | 272 | 0.170 |
Why?
|
| Healthy Lifestyle | 1 | 2020 | 31 | 0.170 |
Why?
|
| Keratins | 1 | 2019 | 54 | 0.170 |
Why?
|
| Pedigree | 3 | 2012 | 1605 | 0.160 |
Why?
|
| Cause of Death | 3 | 2014 | 473 | 0.160 |
Why?
|
| Nutrition Policy | 3 | 2020 | 102 | 0.160 |
Why?
|
| Leptin | 2 | 2024 | 216 | 0.160 |
Why?
|
| Butylene Glycols | 1 | 2018 | 1 | 0.160 |
Why?
|
| Acetoacetates | 1 | 2018 | 21 | 0.160 |
Why?
|
| Diet Records | 2 | 2016 | 74 | 0.160 |
Why?
|
| Odds Ratio | 3 | 2012 | 1254 | 0.160 |
Why?
|
| Developed Countries | 1 | 2019 | 37 | 0.150 |
Why?
|
| Turkey | 1 | 2018 | 59 | 0.150 |
Why?
|
| Adenoviridae Infections | 2 | 2013 | 71 | 0.150 |
Why?
|
| New York | 2 | 2016 | 69 | 0.150 |
Why?
|
| Alabama | 7 | 2016 | 45 | 0.150 |
Why?
|
| Skin | 2 | 2019 | 520 | 0.150 |
Why?
|
| Siblings | 2 | 2012 | 197 | 0.150 |
Why?
|
| Weaning | 1 | 2018 | 44 | 0.150 |
Why?
|
| Thermogenesis | 1 | 2018 | 46 | 0.150 |
Why?
|
| Estrous Cycle | 1 | 2018 | 35 | 0.150 |
Why?
|
| Biomarkers | 4 | 2022 | 3063 | 0.140 |
Why?
|
| Smoking | 3 | 2012 | 1045 | 0.140 |
Why?
|
| Patient Dropouts | 3 | 2015 | 51 | 0.140 |
Why?
|
| Science | 1 | 2018 | 33 | 0.140 |
Why?
|
| Prospective Studies | 8 | 2020 | 6135 | 0.140 |
Why?
|
| Genetics, Behavioral | 1 | 1997 | 10 | 0.140 |
Why?
|
| National Institutes of Health (U.S.) | 1 | 2018 | 133 | 0.140 |
Why?
|
| Caregivers | 1 | 2023 | 560 | 0.140 |
Why?
|
| Self Concept | 1 | 1998 | 155 | 0.140 |
Why?
|
| Benzhydryl Compounds | 1 | 2018 | 66 | 0.140 |
Why?
|
| Bone Density | 3 | 2012 | 319 | 0.140 |
Why?
|
| RNA, Messenger | 5 | 2008 | 2816 | 0.140 |
Why?
|
| Taste Threshold | 1 | 2017 | 1 | 0.140 |
Why?
|
| Databases, Factual | 2 | 2014 | 1179 | 0.140 |
Why?
|
| Taste | 1 | 2017 | 31 | 0.140 |
Why?
|
| Students | 1 | 2019 | 248 | 0.140 |
Why?
|
| Arousal | 1 | 2017 | 80 | 0.140 |
Why?
|
| Social Stigma | 1 | 2017 | 69 | 0.130 |
Why?
|
| Homeostasis | 2 | 2018 | 685 | 0.130 |
Why?
|
| Sensitivity and Specificity | 4 | 2014 | 2050 | 0.130 |
Why?
|
| Congresses as Topic | 2 | 2014 | 173 | 0.130 |
Why?
|
| Visual Analog Scale | 1 | 2016 | 7 | 0.130 |
Why?
|
| Hippocampus | 1 | 2022 | 821 | 0.130 |
Why?
|
| Epidemiologic Methods | 1 | 2016 | 110 | 0.130 |
Why?
|
| Clinical Trials as Topic | 3 | 2008 | 1089 | 0.130 |
Why?
|
| Parks, Recreational | 1 | 2016 | 2 | 0.130 |
Why?
|
| Mitochondria | 1 | 2021 | 682 | 0.130 |
Why?
|
| Central Nervous System Stimulants | 1 | 2017 | 127 | 0.130 |
Why?
|
| Affect | 1 | 2017 | 154 | 0.130 |
Why?
|
| Lipids | 3 | 2008 | 514 | 0.130 |
Why?
|
| Diet, Mediterranean | 1 | 2015 | 12 | 0.130 |
Why?
|
| Access to Information | 1 | 2016 | 40 | 0.130 |
Why?
|
| Fatty Acids, Monounsaturated | 1 | 2015 | 48 | 0.130 |
Why?
|
| Diet, Carbohydrate-Restricted | 1 | 2015 | 25 | 0.130 |
Why?
|
| Programming Languages | 2 | 2006 | 19 | 0.130 |
Why?
|
| Adolescent Nutritional Physiological Phenomena | 1 | 2015 | 33 | 0.120 |
Why?
|
| Least-Squares Analysis | 2 | 2012 | 31 | 0.120 |
Why?
|
| Homozygote | 2 | 2009 | 548 | 0.120 |
Why?
|
| Calorimetry, Indirect | 2 | 2007 | 56 | 0.120 |
Why?
|
| Reimbursement, Incentive | 2 | 2007 | 47 | 0.120 |
Why?
|
| Functional Food | 1 | 2015 | 2 | 0.120 |
Why?
|
| Hyperuricemia | 1 | 2015 | 37 | 0.120 |
Why?
|
| Gene-Environment Interaction | 1 | 2015 | 121 | 0.120 |
Why?
|
| Delayed-Action Preparations | 2 | 2011 | 110 | 0.120 |
Why?
|
| Pregnancy, Animal | 1 | 2015 | 76 | 0.120 |
Why?
|
| Pharmacogenetics | 2 | 2006 | 184 | 0.120 |
Why?
|
| Health Services Research | 1 | 2016 | 187 | 0.120 |
Why?
|
| Research Subjects | 1 | 2014 | 54 | 0.110 |
Why?
|
| Secondary Prevention | 1 | 2015 | 217 | 0.110 |
Why?
|
| Area Under Curve | 2 | 2012 | 319 | 0.110 |
Why?
|
| Paternal Behavior | 1 | 2014 | 12 | 0.110 |
Why?
|
| Portion Size | 1 | 2014 | 16 | 0.110 |
Why?
|
| United States Food and Drug Administration | 2 | 2012 | 149 | 0.110 |
Why?
|
| Africa South of the Sahara | 2 | 2011 | 115 | 0.110 |
Why?
|
| Child Development | 2 | 2013 | 267 | 0.110 |
Why?
|
| Twin Studies as Topic | 2 | 2008 | 15 | 0.110 |
Why?
|
| Coronary Vessels | 1 | 2017 | 537 | 0.110 |
Why?
|
| Triglycerides | 2 | 2007 | 575 | 0.110 |
Why?
|
| Body Image | 1 | 1993 | 38 | 0.110 |
Why?
|
| Endpoint Determination | 1 | 2013 | 56 | 0.110 |
Why?
|
| Arthritis, Rheumatoid | 2 | 2009 | 262 | 0.110 |
Why?
|
| Pelvic Bones | 1 | 2013 | 26 | 0.110 |
Why?
|
| Heart Rate | 1 | 2016 | 590 | 0.110 |
Why?
|
| Deuterium | 3 | 2022 | 109 | 0.110 |
Why?
|
| Family Health | 1 | 2014 | 258 | 0.100 |
Why?
|
| Skinfold Thickness | 2 | 2003 | 31 | 0.100 |
Why?
|
| Internet | 2 | 2006 | 375 | 0.100 |
Why?
|
| ROC Curve | 2 | 2012 | 569 | 0.100 |
Why?
|
| Gout | 1 | 2015 | 148 | 0.100 |
Why?
|
| Normal Distribution | 1 | 2012 | 17 | 0.100 |
Why?
|
| Satiety Response | 3 | 2005 | 32 | 0.100 |
Why?
|
| Risk Assessment | 3 | 2011 | 3445 | 0.100 |
Why?
|
| Case-Control Studies | 3 | 2009 | 3281 | 0.100 |
Why?
|
| Isotopes | 1 | 2012 | 27 | 0.100 |
Why?
|
| Indicator Dilution Techniques | 1 | 2012 | 25 | 0.100 |
Why?
|
| Species Specificity | 2 | 2010 | 549 | 0.100 |
Why?
|
| Body Water | 1 | 2012 | 90 | 0.100 |
Why?
|
| Accidents, Traffic | 1 | 2012 | 108 | 0.100 |
Why?
|
| Pregnancy Outcome | 1 | 2015 | 588 | 0.100 |
Why?
|
| Urban Health | 2 | 2014 | 76 | 0.090 |
Why?
|
| Markov Chains | 3 | 2011 | 84 | 0.090 |
Why?
|
| Streptococcus mutans | 1 | 2011 | 1 | 0.090 |
Why?
|
| Dental Plaque | 1 | 2011 | 5 | 0.090 |
Why?
|
| Menu Planning | 1 | 2011 | 8 | 0.090 |
Why?
|
| Disease Models, Animal | 6 | 2022 | 4352 | 0.090 |
Why?
|
| Kidney Diseases | 1 | 2015 | 480 | 0.090 |
Why?
|
| Callithrix | 1 | 2010 | 10 | 0.090 |
Why?
|
| Program Evaluation | 1 | 2013 | 442 | 0.090 |
Why?
|
| Pan troglodytes | 1 | 2010 | 71 | 0.090 |
Why?
|
| Bibliometrics | 1 | 2010 | 31 | 0.090 |
Why?
|
| Chromosomes, Human, Pair 8 | 1 | 2011 | 78 | 0.090 |
Why?
|
| Rest | 1 | 2010 | 57 | 0.090 |
Why?
|
| Empirical Research | 2 | 2014 | 9 | 0.090 |
Why?
|
| Cats | 1 | 2010 | 118 | 0.090 |
Why?
|
| Macaca | 1 | 2010 | 61 | 0.090 |
Why?
|
| Muscle Fibers, Skeletal | 1 | 2011 | 94 | 0.090 |
Why?
|
| Preventive Health Services | 1 | 2011 | 60 | 0.090 |
Why?
|
| Chromosomes, Human, Pair 2 | 1 | 2011 | 118 | 0.090 |
Why?
|
| Food Additives | 1 | 2010 | 6 | 0.090 |
Why?
|
| Epidemics | 1 | 2010 | 54 | 0.090 |
Why?
|
| Biomarkers, Tumor | 2 | 2010 | 1485 | 0.090 |
Why?
|
| Antimetabolites | 1 | 2010 | 33 | 0.090 |
Why?
|
| Socioeconomic Factors | 2 | 2011 | 866 | 0.080 |
Why?
|
| Commerce | 1 | 2010 | 50 | 0.080 |
Why?
|
| Primates | 1 | 2010 | 77 | 0.080 |
Why?
|
| Chromosomes, Human, Pair 15 | 1 | 2011 | 160 | 0.080 |
Why?
|
| Patient Selection | 1 | 2013 | 693 | 0.080 |
Why?
|
| Body Temperature | 1 | 2010 | 115 | 0.080 |
Why?
|
| Drug Industry | 1 | 2009 | 46 | 0.080 |
Why?
|
| Dogs | 1 | 2010 | 768 | 0.080 |
Why?
|
| Patient Satisfaction | 1 | 2013 | 475 | 0.080 |
Why?
|
| Polymerase Chain Reaction | 2 | 2011 | 1586 | 0.080 |
Why?
|
| Sequence Analysis, DNA | 2 | 2006 | 1758 | 0.080 |
Why?
|
| Quetiapine Fumarate | 2 | 2007 | 16 | 0.080 |
Why?
|
| Dibenzothiazepines | 2 | 2007 | 14 | 0.080 |
Why?
|
| Wounds and Injuries | 1 | 2012 | 372 | 0.080 |
Why?
|
| Nutritional Requirements | 3 | 2018 | 181 | 0.080 |
Why?
|
| Meals | 2 | 2023 | 57 | 0.080 |
Why?
|
| Body Temperature Regulation | 1 | 2008 | 42 | 0.080 |
Why?
|
| Scavenger Receptors, Class B | 1 | 2008 | 7 | 0.080 |
Why?
|
| Lymphatic Metastasis | 1 | 2010 | 414 | 0.080 |
Why?
|
| Sirolimus | 1 | 2010 | 223 | 0.080 |
Why?
|
| Benzodiazepines | 2 | 2007 | 98 | 0.070 |
Why?
|
| Growth | 1 | 2008 | 106 | 0.070 |
Why?
|
| Environment, Controlled | 1 | 2008 | 8 | 0.070 |
Why?
|
| Dissent and Disputes | 1 | 2008 | 32 | 0.070 |
Why?
|
| Health Status Disparities | 1 | 2011 | 227 | 0.070 |
Why?
|
| Fenofibrate | 1 | 2008 | 59 | 0.070 |
Why?
|
| Sex Characteristics | 3 | 2004 | 314 | 0.070 |
Why?
|
| Residence Characteristics | 1 | 2010 | 277 | 0.070 |
Why?
|
| Muscle Cells | 1 | 2007 | 24 | 0.070 |
Why?
|
| Yogurt | 1 | 2007 | 13 | 0.070 |
Why?
|
| Hormones | 1 | 2008 | 186 | 0.070 |
Why?
|
| Chromosomes, Human | 1 | 2008 | 130 | 0.070 |
Why?
|
| Muscle Proteins | 1 | 2010 | 417 | 0.070 |
Why?
|
| Insurance, Health, Reimbursement | 1 | 2007 | 33 | 0.070 |
Why?
|
| HIV-1 | 1 | 2011 | 465 | 0.070 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2010 | 1231 | 0.070 |
Why?
|
| Trans Fatty Acids | 1 | 2007 | 10 | 0.070 |
Why?
|
| United Kingdom | 1 | 2008 | 189 | 0.070 |
Why?
|
| Confidence Intervals | 1 | 2008 | 284 | 0.070 |
Why?
|
| Signal Transduction | 3 | 2021 | 4505 | 0.070 |
Why?
|
| Decision Making | 1 | 2012 | 655 | 0.070 |
Why?
|
| Evolution, Molecular | 1 | 2010 | 669 | 0.070 |
Why?
|
| Dietary Fats, Unsaturated | 1 | 2007 | 33 | 0.070 |
Why?
|
| Interprofessional Relations | 1 | 2008 | 143 | 0.070 |
Why?
|
| Enzyme Inhibitors | 1 | 2010 | 579 | 0.070 |
Why?
|
| Antigens, CD | 1 | 2009 | 420 | 0.070 |
Why?
|
| False Positive Reactions | 2 | 2009 | 144 | 0.070 |
Why?
|
| Body Size | 1 | 2007 | 55 | 0.070 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2010 | 1689 | 0.070 |
Why?
|
| Bison | 1 | 2006 | 1 | 0.070 |
Why?
|
| Hyperinsulinism | 1 | 2007 | 67 | 0.070 |
Why?
|
| Endocrine System | 1 | 2006 | 22 | 0.070 |
Why?
|
| Hypolipidemic Agents | 1 | 2008 | 180 | 0.070 |
Why?
|
| Informed Consent | 1 | 2009 | 334 | 0.070 |
Why?
|
| Thymidylate Synthase | 1 | 2006 | 22 | 0.070 |
Why?
|
| Qualitative Research | 1 | 2009 | 539 | 0.070 |
Why?
|
| Lunch | 2 | 2018 | 14 | 0.070 |
Why?
|
| Family Characteristics | 1 | 2006 | 72 | 0.070 |
Why?
|
| Diet Surveys | 2 | 2006 | 98 | 0.070 |
Why?
|
| Thymus Gland | 2 | 2003 | 101 | 0.060 |
Why?
|
| Environmental Exposure | 1 | 2008 | 221 | 0.060 |
Why?
|
| Societies, Medical | 2 | 2007 | 693 | 0.060 |
Why?
|
| Genes, Plant | 1 | 2006 | 27 | 0.060 |
Why?
|
| Principal Component Analysis | 1 | 2006 | 142 | 0.060 |
Why?
|
| Peptide YY | 1 | 2005 | 19 | 0.060 |
Why?
|
| Endopeptidases | 1 | 2006 | 114 | 0.060 |
Why?
|
| Maternal Age | 1 | 2006 | 134 | 0.060 |
Why?
|
| Adipose Tissue, Brown | 2 | 2018 | 74 | 0.060 |
Why?
|
| Microsatellite Repeats | 1 | 2006 | 221 | 0.060 |
Why?
|
| Plant Proteins | 1 | 2006 | 75 | 0.060 |
Why?
|
| Catechol O-Methyltransferase | 1 | 2005 | 25 | 0.060 |
Why?
|
| Software Design | 1 | 2005 | 24 | 0.060 |
Why?
|
| Arabidopsis | 1 | 2006 | 70 | 0.060 |
Why?
|
| Genetic Diseases, Inborn | 1 | 2009 | 443 | 0.060 |
Why?
|
| Computer Graphics | 1 | 2005 | 38 | 0.060 |
Why?
|
| Database Management Systems | 1 | 2005 | 31 | 0.060 |
Why?
|
| Neurodegenerative Diseases | 1 | 2008 | 249 | 0.060 |
Why?
|
| Microarray Analysis | 1 | 2006 | 229 | 0.060 |
Why?
|
| Computers | 1 | 2005 | 68 | 0.060 |
Why?
|
| Ephedra sinica | 1 | 2004 | 1 | 0.060 |
Why?
|
| Cola | 1 | 2004 | 1 | 0.060 |
Why?
|
| Salix | 1 | 2004 | 1 | 0.060 |
Why?
|
| Mental Recall | 1 | 2006 | 143 | 0.060 |
Why?
|
| Molecular Probe Techniques | 1 | 2005 | 23 | 0.060 |
Why?
|
| Ephedrine | 1 | 2004 | 5 | 0.060 |
Why?
|
| DNA, Complementary | 1 | 2006 | 461 | 0.060 |
Why?
|
| Serum | 1 | 2005 | 45 | 0.060 |
Why?
|
| Benzyl Alcohols | 1 | 2004 | 15 | 0.060 |
Why?
|
| Adipogenesis | 1 | 2005 | 70 | 0.060 |
Why?
|
| Microtubule-Associated Proteins | 1 | 2006 | 244 | 0.060 |
Why?
|
| Logic | 1 | 2004 | 9 | 0.060 |
Why?
|
| Thiazoles | 1 | 2005 | 98 | 0.060 |
Why?
|
| Mathematics | 1 | 2004 | 98 | 0.060 |
Why?
|
| Tobacco Use Disorder | 1 | 2005 | 89 | 0.060 |
Why?
|
| HIV Infections | 2 | 2011 | 1893 | 0.060 |
Why?
|
| Chromatography, Liquid | 1 | 2005 | 196 | 0.060 |
Why?
|
| Lipase | 1 | 2004 | 93 | 0.060 |
Why?
|
| User-Computer Interface | 1 | 2005 | 154 | 0.060 |
Why?
|
| Intention to Treat Analysis | 2 | 2015 | 64 | 0.060 |
Why?
|
| Protein Isoforms | 1 | 2005 | 406 | 0.060 |
Why?
|
| Potassium Channel Blockers | 1 | 2004 | 83 | 0.050 |
Why?
|
| Adenoviridae | 1 | 2006 | 606 | 0.050 |
Why?
|
| Mass Spectrometry | 1 | 2005 | 330 | 0.050 |
Why?
|
| Disease Transmission, Infectious | 1 | 2004 | 84 | 0.050 |
Why?
|
| Disease Progression | 1 | 2010 | 2048 | 0.050 |
Why?
|
| Hordeum | 1 | 2003 | 5 | 0.050 |
Why?
|
| Sequence Alignment | 1 | 2005 | 622 | 0.050 |
Why?
|
| Heterotrimeric GTP-Binding Proteins | 1 | 2003 | 28 | 0.050 |
Why?
|
| Stochastic Processes | 1 | 2003 | 34 | 0.050 |
Why?
|
| Piperazines | 1 | 2005 | 236 | 0.050 |
Why?
|
| Apolipoprotein A-I | 1 | 2003 | 81 | 0.050 |
Why?
|
| Soybean Proteins | 1 | 2003 | 17 | 0.050 |
Why?
|
| Sickness Impact Profile | 1 | 2003 | 36 | 0.050 |
Why?
|
| Chromosomes, Human, Pair 12 | 1 | 2003 | 94 | 0.050 |
Why?
|
| Self-Assessment | 1 | 2003 | 66 | 0.050 |
Why?
|
| Plethysmography, Impedance | 1 | 2002 | 2 | 0.050 |
Why?
|
| Dietary Fiber | 1 | 2003 | 74 | 0.050 |
Why?
|
| Rats, Wistar | 1 | 2004 | 359 | 0.050 |
Why?
|
| Progestins | 1 | 2023 | 48 | 0.050 |
Why?
|
| Chromosomes, Human, Pair 1 | 1 | 2003 | 140 | 0.050 |
Why?
|
| Structure-Activity Relationship | 1 | 2004 | 575 | 0.050 |
Why?
|
| Luteinizing Hormone | 1 | 2023 | 131 | 0.050 |
Why?
|
| Adjuvants, Pharmaceutic | 1 | 2022 | 12 | 0.050 |
Why?
|
| Videotape Recording | 1 | 2002 | 57 | 0.050 |
Why?
|
| Schizophrenic Psychology | 1 | 2003 | 82 | 0.050 |
Why?
|
| Glioblastoma | 1 | 2006 | 327 | 0.050 |
Why?
|
| Adenoviruses, Human | 1 | 2002 | 81 | 0.050 |
Why?
|
| Follicle Stimulating Hormone | 1 | 2023 | 186 | 0.050 |
Why?
|
| False Negative Reactions | 1 | 2002 | 89 | 0.050 |
Why?
|
| Heart Diseases | 1 | 2007 | 490 | 0.050 |
Why?
|
| Hypertension | 1 | 2011 | 1320 | 0.050 |
Why?
|
| Neoplasm Proteins | 1 | 2006 | 669 | 0.050 |
Why?
|
| Genetic Loci | 2 | 2015 | 339 | 0.050 |
Why?
|
| Arm | 1 | 2002 | 81 | 0.050 |
Why?
|
| Health | 1 | 2001 | 36 | 0.050 |
Why?
|
| Thinness | 1 | 2002 | 70 | 0.050 |
Why?
|
| Orexins | 2 | 2013 | 7 | 0.050 |
Why?
|
| Immune System | 1 | 2002 | 90 | 0.050 |
Why?
|
| Epigenesis, Genetic | 1 | 2006 | 673 | 0.050 |
Why?
|
| Abdomen | 1 | 2002 | 127 | 0.050 |
Why?
|
| Cholesterol, HDL | 1 | 2003 | 358 | 0.050 |
Why?
|
| Uncoupling Protein 1 | 2 | 2013 | 26 | 0.050 |
Why?
|
| Promoter Regions, Genetic | 1 | 2005 | 1328 | 0.050 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2004 | 681 | 0.040 |
Why?
|
| Glycoside Hydrolase Inhibitors | 1 | 2020 | 3 | 0.040 |
Why?
|
| Long-Term Potentiation | 1 | 2022 | 163 | 0.040 |
Why?
|
| Social Behavior | 1 | 2002 | 209 | 0.040 |
Why?
|
| Risk Reduction Behavior | 1 | 2021 | 142 | 0.040 |
Why?
|
| Neuropeptides | 2 | 2013 | 113 | 0.040 |
Why?
|
| Receptors, Neuropeptide Y | 2 | 2013 | 8 | 0.040 |
Why?
|
| Multivariate Analysis | 2 | 2014 | 1428 | 0.040 |
Why?
|
| Ion Channels | 2 | 2013 | 191 | 0.040 |
Why?
|
| Mitochondrial Proteins | 2 | 2013 | 229 | 0.040 |
Why?
|
| Accelerometry | 1 | 2019 | 60 | 0.040 |
Why?
|
| Hypothalamus | 2 | 2013 | 221 | 0.040 |
Why?
|
| Reference Values | 2 | 2015 | 712 | 0.040 |
Why?
|
| Military Personnel | 1 | 2021 | 212 | 0.040 |
Why?
|
| Citrates | 1 | 1998 | 22 | 0.040 |
Why?
|
| Mice, Obese | 1 | 2018 | 73 | 0.040 |
Why?
|
| Cost-Benefit Analysis | 1 | 2021 | 510 | 0.040 |
Why?
|
| Transcription Factors | 2 | 2007 | 2584 | 0.040 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 2 | 2013 | 555 | 0.040 |
Why?
|
| Adipose Tissue, White | 1 | 2018 | 76 | 0.040 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2009 | 3554 | 0.040 |
Why?
|
| Taste Perception | 1 | 2017 | 5 | 0.030 |
Why?
|
| Brain Neoplasms | 1 | 2006 | 1207 | 0.030 |
Why?
|
| Europe | 2 | 2011 | 354 | 0.030 |
Why?
|
| Social Environment | 1 | 1997 | 120 | 0.030 |
Why?
|
| Daphnia | 1 | 2016 | 2 | 0.030 |
Why?
|
| Urban Renewal | 1 | 2016 | 1 | 0.030 |
Why?
|
| Macaca mulatta | 2 | 2011 | 491 | 0.030 |
Why?
|
| Africa | 2 | 2011 | 133 | 0.030 |
Why?
|
| Incidence | 2 | 2015 | 3138 | 0.030 |
Why?
|
| Glycemic Index | 1 | 2015 | 19 | 0.030 |
Why?
|
| Body Weight Maintenance | 1 | 2015 | 4 | 0.030 |
Why?
|
| Denmark | 1 | 2015 | 33 | 0.030 |
Why?
|
| Calorimetry | 1 | 1995 | 61 | 0.030 |
Why?
|
| Massachusetts | 1 | 2015 | 126 | 0.030 |
Why?
|
| Spatial Learning | 1 | 2015 | 15 | 0.030 |
Why?
|
| Mice, Inbred DBA | 2 | 2006 | 48 | 0.030 |
Why?
|
| World Health Organization | 1 | 2015 | 101 | 0.030 |
Why?
|
| Mice, Inbred Strains | 2 | 2006 | 307 | 0.030 |
Why?
|
| Plaque, Amyloid | 1 | 2015 | 64 | 0.030 |
Why?
|
| Dentate Gyrus | 1 | 2015 | 53 | 0.030 |
Why?
|
| Data Accuracy | 1 | 2014 | 25 | 0.030 |
Why?
|
| Cholelithiasis | 1 | 1994 | 16 | 0.030 |
Why?
|
| Glucose Intolerance | 1 | 2015 | 78 | 0.030 |
Why?
|
| Nonlinear Dynamics | 1 | 2014 | 51 | 0.030 |
Why?
|
| Policy Making | 1 | 2014 | 58 | 0.030 |
Why?
|
| Microglia | 1 | 2015 | 101 | 0.030 |
Why?
|
| Human Body | 1 | 1993 | 1 | 0.030 |
Why?
|
| Suppressor of Cytokine Signaling 3 Protein | 1 | 2013 | 11 | 0.030 |
Why?
|
| Suppressor of Cytokine Signaling Proteins | 1 | 2013 | 23 | 0.030 |
Why?
|
| Receptors, Glucagon | 1 | 2013 | 28 | 0.030 |
Why?
|
| Culture | 1 | 1993 | 68 | 0.030 |
Why?
|
| Agouti-Related Protein | 1 | 2013 | 42 | 0.030 |
Why?
|
| Food Services | 1 | 2013 | 39 | 0.030 |
Why?
|
| Carbazoles | 1 | 2013 | 33 | 0.030 |
Why?
|
| Behavioral Risk Factor Surveillance System | 1 | 2013 | 52 | 0.030 |
Why?
|
| Morpholines | 1 | 2013 | 57 | 0.030 |
Why?
|
| Geography | 1 | 2013 | 113 | 0.030 |
Why?
|
| Glucagon-Like Peptide-1 Receptor | 1 | 2013 | 62 | 0.030 |
Why?
|
| Finite Element Analysis | 1 | 2012 | 28 | 0.030 |
Why?
|
| Philadelphia | 1 | 2012 | 26 | 0.030 |
Why?
|
| Brain-Derived Neurotrophic Factor | 1 | 2013 | 115 | 0.020 |
Why?
|
| Self Care | 1 | 2014 | 212 | 0.020 |
Why?
|
| Biomechanical Phenomena | 1 | 2012 | 243 | 0.020 |
Why?
|
| Time | 1 | 2011 | 93 | 0.020 |
Why?
|
| Middle East | 1 | 2011 | 34 | 0.020 |
Why?
|
| Blotting, Southern | 1 | 2011 | 215 | 0.020 |
Why?
|
| Americas | 1 | 2011 | 50 | 0.020 |
Why?
|
| STAT3 Transcription Factor | 1 | 2013 | 222 | 0.020 |
Why?
|
| Survival Rate | 1 | 2016 | 2044 | 0.020 |
Why?
|
| Asia | 1 | 2011 | 107 | 0.020 |
Why?
|
| DNA Fingerprinting | 1 | 2011 | 107 | 0.020 |
Why?
|
| Bacterial Typing Techniques | 1 | 2011 | 102 | 0.020 |
Why?
|
| Gene Expression Regulation, Neoplastic | 2 | 2010 | 1895 | 0.020 |
Why?
|
| Comorbidity | 1 | 2015 | 1529 | 0.020 |
Why?
|
| Geographic Information Systems | 1 | 2010 | 41 | 0.020 |
Why?
|
| Gene Library | 1 | 2011 | 217 | 0.020 |
Why?
|
| Leukocytes | 1 | 2011 | 205 | 0.020 |
Why?
|
| Repetitive Sequences, Nucleic Acid | 1 | 2011 | 369 | 0.020 |
Why?
|
| Magnetic Resonance Spectroscopy | 1 | 2011 | 289 | 0.020 |
Why?
|
| Fetal Death | 1 | 2010 | 112 | 0.020 |
Why?
|
| Cells, Cultured | 2 | 2007 | 3040 | 0.020 |
Why?
|
| Ovulation | 1 | 2010 | 109 | 0.020 |
Why?
|
| Fasting | 1 | 2011 | 298 | 0.020 |
Why?
|
| DNA, Bacterial | 1 | 2011 | 478 | 0.020 |
Why?
|
| Electronic Health Records | 1 | 2016 | 723 | 0.020 |
Why?
|
| Uncoupling Protein 3 | 1 | 2008 | 6 | 0.020 |
Why?
|
| CTLA-4 Antigen | 1 | 2009 | 53 | 0.020 |
Why?
|
| Breeding | 1 | 2008 | 20 | 0.020 |
Why?
|
| Urban Population | 1 | 2010 | 225 | 0.020 |
Why?
|
| Clinical Protocols | 1 | 2010 | 240 | 0.020 |
Why?
|
| Seasons | 1 | 2010 | 310 | 0.020 |
Why?
|
| CD36 Antigens | 1 | 2008 | 37 | 0.020 |
Why?
|
| Mice, Mutant Strains | 1 | 2008 | 383 | 0.020 |
Why?
|
| Organ Size | 1 | 2008 | 425 | 0.020 |
Why?
|
| Societies, Scientific | 1 | 2007 | 26 | 0.020 |
Why?
|
| Liver | 1 | 1994 | 1739 | 0.020 |
Why?
|
| Genetic Association Studies | 1 | 2011 | 778 | 0.020 |
Why?
|
| Glucose Clamp Technique | 1 | 2007 | 76 | 0.020 |
Why?
|
| Nuclear Receptor Subfamily 4, Group A, Member 1 | 1 | 2007 | 33 | 0.020 |
Why?
|
| Benchmarking | 1 | 2007 | 134 | 0.020 |
Why?
|
| Inhibitor of Apoptosis Proteins | 1 | 2006 | 46 | 0.020 |
Why?
|
| Ubiquitin Thiolesterase | 1 | 2006 | 58 | 0.020 |
Why?
|
| Metabolic Networks and Pathways | 1 | 2007 | 187 | 0.020 |
Why?
|
| Dipeptidyl Peptidase 4 | 1 | 2005 | 21 | 0.020 |
Why?
|
| Mice, Inbred ICR | 1 | 2006 | 152 | 0.020 |
Why?
|
| T-Lymphocyte Subsets | 1 | 2006 | 196 | 0.020 |
Why?
|
| Inbreeding | 1 | 2005 | 8 | 0.020 |
Why?
|
| Transgenes | 1 | 2006 | 334 | 0.020 |
Why?
|
| Receptors, Steroid | 1 | 2007 | 275 | 0.020 |
Why?
|
| Consumer Product Safety | 1 | 2005 | 29 | 0.020 |
Why?
|
| Electrophoretic Mobility Shift Assay | 1 | 2005 | 49 | 0.020 |
Why?
|
| Texas | 1 | 2014 | 3584 | 0.020 |
Why?
|
| Biometry | 1 | 2006 | 136 | 0.020 |
Why?
|
| Drug Administration Schedule | 1 | 2007 | 721 | 0.020 |
Why?
|
| Equipment Design | 1 | 2007 | 598 | 0.010 |
Why?
|
| Administration, Oral | 1 | 2007 | 680 | 0.010 |
Why?
|
| Health Care Costs | 1 | 2007 | 371 | 0.010 |
Why?
|
| DNA Copy Number Variations | 1 | 2010 | 949 | 0.010 |
Why?
|
| Safety | 1 | 2005 | 219 | 0.010 |
Why?
|
| Matrix Metalloproteinase 1 | 1 | 2004 | 25 | 0.010 |
Why?
|
| Synovial Membrane | 1 | 2004 | 27 | 0.010 |
Why?
|
| Disease-Free Survival | 1 | 2006 | 869 | 0.010 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2007 | 1284 | 0.010 |
Why?
|
| Receptors, Cytoplasmic and Nuclear | 1 | 2007 | 376 | 0.010 |
Why?
|
| Gene Expression | 1 | 2008 | 1562 | 0.010 |
Why?
|
| T-Lymphocytes, Cytotoxic | 1 | 2006 | 503 | 0.010 |
Why?
|
| Chromosomes | 1 | 2004 | 199 | 0.010 |
Why?
|
| Disease Management | 1 | 2007 | 523 | 0.010 |
Why?
|
| Stress, Physiological | 1 | 2005 | 255 | 0.010 |
Why?
|
| Chromosomes, Mammalian | 1 | 2003 | 41 | 0.010 |
Why?
|
| Osmolar Concentration | 1 | 2003 | 176 | 0.010 |
Why?
|
| Callitrichinae | 1 | 2002 | 1 | 0.010 |
Why?
|
| C-Peptide | 1 | 2003 | 113 | 0.010 |
Why?
|
| RNA | 1 | 2006 | 570 | 0.010 |
Why?
|
| DNA | 1 | 2008 | 1597 | 0.010 |
Why?
|
| Cell Division | 1 | 2004 | 777 | 0.010 |
Why?
|
| History, 20th Century | 1 | 2003 | 383 | 0.010 |
Why?
|
| RNA, Small Interfering | 1 | 2004 | 660 | 0.010 |
Why?
|
| Peptide Fragments | 1 | 2005 | 779 | 0.010 |
Why?
|
| NF-kappa B | 1 | 2004 | 455 | 0.010 |
Why?
|
| Cooperative Behavior | 1 | 2002 | 218 | 0.010 |
Why?
|
| Drosophila melanogaster | 1 | 2005 | 771 | 0.010 |
Why?
|
| Fibroblasts | 1 | 2004 | 882 | 0.010 |
Why?
|
| Patient Acceptance of Health Care | 1 | 2003 | 420 | 0.010 |
Why?
|
| Genetic Testing | 1 | 2005 | 1001 | 0.010 |
Why?
|
| Electric Impedance | 1 | 1999 | 57 | 0.010 |
Why?
|
| DNA-Binding Proteins | 1 | 2007 | 2045 | 0.010 |
Why?
|
| Apoptosis | 1 | 2004 | 1789 | 0.010 |
Why?
|
| Antibodies, Viral | 1 | 2002 | 1151 | 0.010 |
Why?
|
| Retrospective Studies | 2 | 2006 | 16317 | 0.010 |
Why?
|
| Liver Function Tests | 1 | 1994 | 100 | 0.010 |
Why?
|
| Aspartate Aminotransferases | 1 | 1994 | 81 | 0.010 |
Why?
|
| Alanine Transaminase | 1 | 1994 | 156 | 0.010 |
Why?
|
| Bilirubin | 1 | 1994 | 123 | 0.010 |
Why?
|
| T-Lymphocytes | 1 | 2002 | 1709 | 0.010 |
Why?
|
| Ultrasonography | 1 | 1994 | 932 | 0.010 |
Why?
|